Three National Cancer Institute-funded post-doctoral research traineeships are available at the University of Arizona Cancer Center in Tucson, Ariz.
The T32 Program offers a multi-disciplinary mentored environment integrating behavioral to biological science research focused on cancer disparities and understanding and preventing cancer.
Click here to view, download and share the flyer for this event!
You have come to the right place!
Sleep disorders are among the most common clinical problems encountered in modern medicine. Strong evidence shows that insufficient sleep has a significant impact on numerous health conditions, including chronic disease development, incidence and immunologic function.
If you missed the Town Hall Meeting of the Academic Management Council, the UA-Banner entity formed as part of the academic affiliation agreement between Banner Health and the University of Arizona to oversee the Banner – University Medicine Division, you can view archived video of the event at the UA Health Sciences Webcast webpage.
Guy Reed, MD, MS
, a noted cardiologist, physician-scientist and health administrator, has been named dean of the University of Arizona College of Medicine – Phoenix.
The announcement was made today by Leigh Neumayer, MD, MS, interim senior vice president, University of Arizona Health Sciences.
Two additional physicians in training within the University of Arizona Department of Medicine have received Bressler-Alpert Travel Awards to assist them in presenting their research at conferences.
SPEAKERS
Anne M. Ryan, JD
Director, Tucson
Family Advocacy
Program, Medical Legal
Partnership for Health
Elizabeth Moran, MD, MPH
Assistant Professor
UA Dept. Family & Community Medicine
Meheria Habibi
Resettlement Supervisor
International Rescue Committee in Tucson
Dr. Rajesh Khanna, associate professor in the Department of Pharmacology, College of Medicine, delivers his pitch for Regulonix and the small molecule inhibitors for chronic pain the company is working to bring to market.
Why are some people barely affected by Valley fever while others are admitted to intensive care?
The search for answers to those questions is on, thanks to a $2.27 million grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health to the University of Arizona Valley Fever Center for Excellence.
Local startup Avery Therapeutics Inc. has licensed a beating heart graft technology invented at the University of Arizona College of Medicine – Tucson. Pre-clinical studies have already shown that the technology, called MyCardia™, improves heart function.
